Health Canada’s rules around psilocybin are often misunderstood. This guide breaks down the Special Access Program, Section 56 exemptions, clinical trials, and what patients and curious Canadians should actually know about accessing psilocybin legally.
Tag Archives: Special Access Program psilocybin
Psilocybin clinical trials in Canada have moved from fringe curiosity to serious medical research. This guide explains how trials are designed and regulated, who can enroll, how Health Canada’s Special Access Program fits in, and what the latest findings on depression, anxiety, and suicidal thoughts actually tell us.

